Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Shortened therapy of eight weeks with paritaprevir/ritonavir/ombitasvir and dasabuvir is highly effective in people with recent HCV genotype 1 infection.
Martinello M, Bhagani S, Gane E, Orkin C, Cooke G, Dore GJ, Petoumenos K, Applegate TL, Tu E, Marks P, Pagani N, Grebely J, Nelson M, Matthews GV. Martinello M, et al. Among authors: marks p. J Viral Hepat. 2018 Oct;25(10):1180-1188. doi: 10.1111/jvh.12917. Epub 2018 May 8. J Viral Hepat. 2018. PMID: 29660224 Clinical Trial.
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M; ATAHC Study Group. Grebely J, et al. Among authors: marks p. Drug Alcohol Depend. 2010 Mar 1;107(2-3):244-9. doi: 10.1016/j.drugalcdep.2009.09.015. Drug Alcohol Depend. 2010. PMID: 19926405 Free PMC article. Clinical Trial.
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study.
Yee J, Carson JM, Hajarizadeh B, Hanson J, O'Beirne J, Iser D, Read P, Balcomb A, Doyle JS, Davies J, Martinello M, Marks P, Dore GJ, Matthews GV; REACH‐C Study Group. Yee J, et al. Among authors: marks p. Hepatol Commun. 2022 Mar;6(3):496-512. doi: 10.1002/hep4.1826. Epub 2021 Nov 2. Hepatol Commun. 2022. PMID: 34729957 Free PMC article.
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.
Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, McCaughan G, Sasadeusz J, White P, Rawlinson W, Lloyd A, Kaldor J, Dore GJ; Australian Trial in Acute Hepatitis C Study Group. Matthews GV, et al. Among authors: marks p. Clin Infect Dis. 2009 Mar 1;48(5):650-8. doi: 10.1086/596770. Clin Infect Dis. 2009. PMID: 19191653 Free PMC article.
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.
Matthews GV, Pham ST, Hellard M, Grebely J, Zhang L, Oon A, Marks P, van Beek I, Rawlinson W, Kaldor JM, Lloyd A, Dore GJ, White PA; ATAHC Study Group. Matthews GV, et al. Among authors: marks p. Clin Infect Dis. 2011 Mar 15;52(6):803-11. doi: 10.1093/cid/ciq200. Epub 2011 Jan 31. Clin Infect Dis. 2011. PMID: 21282185 Free PMC article. Clinical Trial.
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
Broady TR, Valerio H, Alavi M, Wheeler A, Silk D, Martinello M, Conway A, Milat A, Dunlop A, Murray C, Henderson C, Amin J, Read P, Marks P, Degenhardt L, Stevens A, Prain B, Hayllar J, Reid D, Montebello M, Wade A, Christmass M, Cock V, Dore GJ, Treloar C, Grebely J; ETHOS Engage Study Group. Broady TR, et al. Among authors: marks p. Int J Drug Policy. 2024 May 24;128:104468. doi: 10.1016/j.drugpo.2024.104468. Online ahead of print. Int J Drug Policy. 2024. PMID: 38795465 Free article.
Long-term functional success and patient-reported outcomes after female one-stage buccal mucosal graft urethroplasty.
Klemm J, Marks P, Schulz RJ, Filipas DK, Stelzl DR, Dahlem R, Fisch M, Vetterlein MW; Trauma and Reconstructive Urology Working Party of the European Association of Urology Young Academic Urologists. Klemm J, et al. Among authors: marks p. Actas Urol Esp (Engl Ed). 2024 May 14:S2173-5786(24)00074-X. doi: 10.1016/j.acuroe.2024.05.014. Online ahead of print. Actas Urol Esp (Engl Ed). 2024. PMID: 38754730 Free article. English, Spanish.
Impact of COVID-19 on the time to counseling and treatment of prostate cancer.
Filipas DK, Pose RM, Marks P, Tennstedt P, Beyer B, Tilki D, Isbarn H, Maurer T, Ludwig TA, Heinzer H, Steuber T. Filipas DK, et al. Among authors: marks p. Aging Male. 2024 Dec;27(1):2347465. doi: 10.1080/13685538.2024.2347465. Epub 2024 May 7. Aging Male. 2024. PMID: 38712892
Achieving Diversity Through Decentralization.
Adashi EY, Marks PW. Adashi EY, et al. Among authors: marks pw. J Gen Intern Med. 2024 May 1. doi: 10.1007/s11606-024-08780-0. Online ahead of print. J Gen Intern Med. 2024. PMID: 38693459 No abstract available.
897 results